Biomolecular corona on nanoparticles: A survey of recent literature and its implications in targeted drug delivery

Frontiers in Chemistry

Volumn 2, Issue NOV, 2014, Pages

  Pearson, Ryan M ^a   Juettner, Vanessa V ^a   Hong, Seungpyo ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b University of Illinois at Chicago   (United States)

Author keywords

Biomolecular corona; In vivo efficacy; Nanoparticle; Targeted drug delivery

Indexed keywords

EID: 84987638579     PISSN: None     EISSN: 22962646     Source Type: Journal    
DOI: 10.3389/fchem.2014.00108     Document Type: Short Survey

References (56)

1. Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., and McNeil, S. E. (2009). Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 61, 428-437. doi: 10.1016/j.addr.2009.03.009
2. Amoozgar, Z., and Yeo, Y. (2012). Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4, 219-233. doi: 10.1002/wnan.1157
3. Ashby, J., Pan, S., and Zhong, W. (2014). Size and surface functionalization of iron oxide nanoparticles influence the composition and dynamic nature of their protein corona. ACS Appl. Mater. Interfaces 6, 15412-15419. doi: 10.1021/am503909q
4. Baugh, J. A., and Donnelly, S. C. (2003). Macrophage migration inhibitory factor: a neuroendocrine modulator of chronic inflammation. J. Endocrinol. 179, 15-23. doi: 10.1677/joe.0.1790015
5. Behzadi, S., Serpooshan, V., Sakhtianchi, R., Müller, B., Landfester, K., Crespy, D., et al. (2014). Protein corona change the drug release profile of nanocarriers: the "overlooked" factor at the nanobio interface. Colloids Surf. B Biointerfaces. doi: 10.1016/j.colsurfb.2014.09.009. [Epub ahead of print].
6. Bertoli, F., Davies, G.-L., Monopoli, M. P., Moloney, M., Gun'ko, Y. K., Salvati, A., et al. (2014). Magnetic nanoparticles to recover cellular organelles and study the time resolved nanoparticle-cell interactome throughout uptake. Small 10, 3307-3315. doi: 10.1002/smll.201303841
7. Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., et al. (2011). Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotechnol. 6, 815-823. doi: 10.1038/nnano.2011.166
8. Cedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., et al. (2007). Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl. Acad. Sci. U.S.A. 104, 2050-2055. doi: 10.1073/pnas.0608582104
9. Chauhan, V. P., and Jain, R. K. (2013). Strategies for advancing cancer nanomedicine. Nat. Mater. 12, 958-962. doi: 10.1038/nmat3792
10. Choi, H. S., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., et al. (2007). Renal clearance of quantum dots. Nat. Biotechnol. 25, 1165-1170. doi: 10.1038/nbt1340
11. Dai, Q., Walkey, C., and Chan, W. C. W. (2014). Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting. Angew. Chem. Int. Ed. Engl. 53, 5093-5096. doi: 10.1002/anie.201309464
12. Fleischer, C. C., and Payne, C. K. (2014). Secondary structure of corona proteins determines the cell surface receptors used by nanoparticles. J. Phys. Chem. B. doi: 10.1021/jp502624n. [Epub ahead of print].
13. Ge, C., Du, J., Zhao, L., Wang, L., Liu, Y., Li, D., et al. (2011). Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 108, 16968-16973. doi: 10.1073/pnas.1105270108
14. Gu, F. X., Karnik, R., Wang, A. Z., Alexis, F., Levy-Nissenbaum, E., Hong, S., et al. (2007). Targeted nanoparticles for cancer therapy. Nano Today 2, 14-21. doi: 10.1016/S1748-0132(07)70083-X
15. Hajipour, M. J., Laurent, S., Aghaie, A., Rezaee, F., and Mahmoudi, M. (2014). Personalized protein coronas: a "key" factor at the nanobiointerface. Biomater. Sci. 2, 1210-1221. doi: 10.1039/C4BM00131A
16. Hellstrand, E., Lynch, I., Andersson, A., Drakenberg, T., Dahlbäck, B., Dawson, K. A., et al. (2009). Complete high-density lipoproteins in nanoparticle corona. FEBS J. 276, 3372-3381. doi: 10.1111/j.1742-4658.2009.07062.x
17. Hubbell, J. A., and Langer, R. (2013). Translating materials design to the clinic. Nat. Mater. 12, 963-966. doi: 10.1038/nmat3788
18. Karlsson, M., Mårtensson, L.-G., Jonsson, B.-H., and Carlsson, U. (2000). Adsorption of human carbonic anhydrase II variants to silica nanoparticles occur stepwise: binding is followed by successive conformational changes to a molten-globule-like state. Langmuir 16, 8470-8479. doi: 10.1021/la0002738
19. Karmali, P. P., and Simberg, D. (2011). Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin. Drug Deliv. 8, 343-357. doi: 10.1517/17425247.2011.554818
20. Lindman, S., Lynch, I., Thulin, E., Nilsson, H., Dawson, K. A., and Linse, S. (2007). Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. Nano Lett. 7, 914-920. doi: 10.1021/nl062743+
21. Linse, S., Cabaleiro-Lago, C., Xue, W. F., Lynch, I., Lindman, S., Thulin, E., et al. (2007). Nucleation of protein fibrillation by nanoparticles. Proc. Natl. Acad. Sci. U.S.A. 104, 8691-8696. doi: 10.1073/pnas.0701250104
22. Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., and Dawson, K. A. (2008). Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U.S.A. 105, 14265-14270. doi: 10.1073/pnas.0805135105
23. Lynch, I., Dawson, K. A., and Linse, S. (2006). Detecting cryptic epitopes created by nanoparticles. Sci. STKE 2006:pe14. doi: 10.1126/stke.3272006pe14
24. Martin, S., Manuela, S.-B., Hakan, S., Shinji, T., Alexander, W., Carsten, S., et al. (2013). Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles. Nanotechnology 24:265103. doi: 10.1088/0957-4484/24/26/265103
25. Milani, S., Baldelli Bombelli, F., Pitek, A. S., Dawson, K. A., and Rädler, J. (2012). Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano 6, 2532-2541. doi: 10.1021/nn204951s
26. Mirshafiee, V., Mahmoudi, M., Lou, K., Cheng, J., and Kraft, M. L. (2013). Protein corona significantly reduces active targeting yield. Chem. Commun. 49, 2557-2559. doi: 10.1039/c3cc37307j
27. Monopoli, M., Pitek, A., Lynch, I., and Dawson, K. (2013). "Formation and characterization of the nanoparticle-protein corona, " in Nanomaterial Interfaces in Biology, eds P. Bergese and K. Hamad-Schifferli (New York, NY: Humana Press), 137-155. doi: 10.1007/978-1-62703-462-3_11
28. Monopoli, M. P., Aberg, C., Salvati, A., and Dawson, K. A. (2012). Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 7, 779-786. doi: 10.1038/nnano.2012.207
29. Mortensen, N. P., Hurst, G. B., Wang, W., Foster, C. M., Nallathamby, P. D., and Retterer, S. T. (2013). Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity. Nanoscale 5, 6372-6380. doi: 10.1039/c3nr33280b
30. Mortimer, G. M., Butcher, N. J., Musumeci, A. W., Deng, Z. J., Martin, D. J., and Minchin, R. F. (2014). Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials. ACS Nano 8, 3357-3366. doi: 10.1021/nn405830g
31. Nel, A. E., Madler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., et al. (2009). Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8, 543-557. doi: 10.1038/nmat2442
32. Owens, D. E. III., and Peppas, N. A. (2006). Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307, 93-102. doi: 10.1016/j.ijpharm.2005.10.010
33. Paula, A. J., Araujo Junior, R. T., Martinez, D. S., Paredes-Gamero, E. J., Nader, H. B., Duran, N., et al. (2013). Influence of protein corona on the transport of molecules into cells by mesoporous silica nanoparticles. ACS Appl. Mater. Interfaces 5, 8387-8393. doi: 10.1021/am4014693
34. Pearson, R. M., Hsu, H.-J., Bugno, J., and Hong, S. (2014). Understanding nano-bio interactions to improve nanocarriers for drug delivery. MRS Bull. 39, 227-237. doi: 10.1557/mrs.2014.9
35. Pearson, R. M., Sunoqrot, S., Hsu, H.-J., Bae, J. W., and Hong, S. (2012). Dendritic nanoparticles: the next generation of nanocarriers? Ther. Deliv. 3, 941-959. doi: 10.4155/tde.12.76
36. Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., and Langer, R. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760. doi: 10.1038/nnano.2007.387
37. Peng, Q., Zhang, S., Yang, Q., Zhang, T., Wei, X.-Q., Jiang, L., et al. (2013). Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. Biomaterials 34, 8521-8530. doi: 10.1016/j.biomaterials.2013.07.102
38. Perry, J. L., Reuter, K. G., Kai, M. P., Herlihy, K. P., Jones, S. W., Luft, J. C., et al. (2012). PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett. 12, 5304-5310. doi: 10.1021/nl302638g
39. Romberg, B., Hennink, W. E., and Storm, G. (2008). Sheddable coatings for long-circulating nanoparticles. Pharm. Res. 25, 55-71. doi: 10.1007/s11095-007-9348-7
40. Sacchetti, C., Motamedchaboki, K., Magrini, A., Palmieri, G., Mattei, M., Bernardini, S., et al. (2013). Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance. ACS Nano 7, 1974-1989. doi: 10.1021/nn400409h
41. Sakulkhu, U., Mahmoudi, M., Maurizi, L., Salaklang, J., and Hofmann, H. (2014a). Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings. Sci. Rep. 4:5020. doi: 10.1038/srep05020
42. Sakulkhu, U., Maurizi, L., Mahmoudi, M., Motazacker, M., Vries, M., Gramoun, A., et al. (2014b). Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats. Nanoscale 6, 11439-11450. doi: 10.1039/C4NR02793K
43. Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., et al. (2013). Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 8, 137-143. doi: 10.1038/nnano.2012.237
44. Saptarshi, S. R., Duschl, A., and Lopata, A. L. (2013). Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J. Nanobiotechnol. 11:26. doi: 10.1186/1477-3155-11-26
45. Shang, L., Wang, Y., Jiang, J., and Dong, S. (2007). pH-dependent protein conformational changes in albumin:gold nanoparticle bioconjugates: a spectroscopic study. Langmuir 23, 2714-2721. doi: 10.1021/la062064e
46. Shannahan, J. H., Lai, X., Ke, P. C., Podila, R., Brown, J. M., and Witzmann, F. A. (2013). Silver nanoparticle protein corona composition in cell culture media. PLoS ONE 8:e74001. doi: 10.1371/journal.pone.0074001
47. Sunoqrot, S., Bugno, J., Lantvit, D., Burdette, J. E., and Hong, S. (2014). Prolonged blood circulation nd enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticles. J. Control. Release 191, 115-122. doi: 10.1016/j.jconrel.2014.05.006
48. Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., et al. (2013). Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 8, 772-781. doi: 10.1038/nnano.2013.181
49. van der Meel, R., Vehmeijer, L. J. C., Kok, R. J., Storm, G., and van Gaal, E. V. B. (2013). Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. Adv. Drug Deliv. Rev. 65, 1284-1298. doi: 10.1016/j.addr.2013.08.012
50. Vroman, L., Adams, A. L., Fischer, G. C., and Munoz, P. C. (1980). Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 55, 156-159.
51. Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., and Chan, W. C. W. (2011). Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 134, 2139-2147. doi: 10.1021/ja2084338
52. Walkey, C. D., Olsen, J. B., Song, F., Liu, R., Guo, H., Olsen, D. W., et al. (2014). Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 8, 2439-2455. doi: 10.1021/nn406018q
53. Wolfram, J., Suri, K., Yang, Y., Shen, J., Celia, C., Fresta, M., et al. (2014b). Shrinkage of pegylated and non-pegylated liposomes in serum. Colloids Surf. B Biointerfaces 114, 294-300. doi: 10.1016/j.colsurfb.2013.10.009
54. Wolfram, J., Yang, Y., Shen, J., Moten, A., Chen, C., Shen, H., et al. (2014a). The nano-plasma interface: implications of the protein corona. Colloids Surf. B Biointerfaces. doi: 10.1016/j.colsurfb.2014.02.035. [Epub ahead of print].
55. Yan, Y., Gause, K. T., Kamphuis, M. M. J., Ang, C.-S., O'Brien-Simpson, N. M., Lenzo, J. C., et al. (2013). Differential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and macrophage cell lines. ACS Nano 7, 10960-10970. doi: 10.1021/nn404481f
56. Zhang, L., Gu, F. X., Chan, J. M., Wang, A. Z., Langer, R. S., and Farokhzad, O. C. (2008). Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 83, 761-769. doi: 10.1038/sj.clpt.6100400